SCHEMBL13259013

SCHEMBL13259013

COc1cc(C(C)(C)c2cnc(SCc3c(F)cc(OCCNC(=N)N)cc3F)n2-c2ccc(C)cc2)ccc1F

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 20/20 0.52
NR1H4 Q96RI1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL602826 0.95 GPBAR1 (0.58) GPBAR1NR1H4
SCHEMBL603734 0.93 GPBAR1 (0.57) GPBAR1NR1H4
SCHEMBL606246 0.90 GPBAR1 (0.62) GPBAR1NR1H4
SCHEMBL604601 0.90 GPBAR1 (0.52) GPBAR1NR1H4
SCHEMBL601745 0.89 GPBAR1 (0.62) GPBAR1NR1H4
SCHEMBL605382 0.88 GPBAR1 (0.61) GPBAR1NR1H4
SCHEMBL604597 0.87 GPBAR1 (0.61) GPBAR1NR1H4
SCHEMBL601798 0.86 GPBAR1 (0.62) GPBAR1NR1H4
Trifluoroacetic Acid SCHEMBL604726 0.85 GPBAR1 (0.57) GPBAR1NR1H4
SCHEMBL602479 0.84 GPBAR1 (0.61) GPBAR1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO disclosed